Finance

Lists
600518:SHA
Kangmei Pharmaceutical Co Ltd
1,31 CN¥
+0,77%
(+0,0100) 1D
19 հոկ, 11:29:54 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600518...
Open
1,29 CN¥
High
1,31 CN¥
Low
1,29 CN¥
Mkt. cap
17,98 մլրդ
Avg. vol.
142,49 մլն
Volume
57,30 մլն
P/E ratio
378,61
52-wk high
2,16 CN¥
52-wk low
1,16 CN¥
EPS
0,00 CN¥
Shares outstanding
4,93 մլրդ
No. of employees
5 հզր
Open
1,29 CN¥
High
1,31 CN¥
Low
1,29 CN¥
Mkt. cap
17,98 մլրդ
Avg. vol.
142,49 մլն
Volume
57,30 մլն
P/E ratio
378,61
52-wk high
2,16 CN¥
52-wk low
1,16 CN¥
EPS
0,00 CN¥
Shares outstanding
4,93 մլրդ
No. of employees
5 հզր
News stories
From web sources and news partners
About Kangmei Pharmaceutical Co Ltd
CEO-
Employees5,49 հզր
Founded18 հնս, 1997 թ.
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
1,38 մլրդ
1,29 մլրդ
1,08 մլրդ
1,21 մլրդ
Cost of goods sold
1,11 մլրդ
1,10 մլրդ
841,45 մլն
969,13 մլն
Cost of revenue
1,11 մլրդ
1,10 մլրդ
841,45 մլն
969,13 մլն
Research and development expenses
14,78 մլն
12,64 մլն
9,66 մլն
4,01 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
274,41 մլն
285,59 մլն
237,06 մլն
253,72 մլն
Operating expense
247,81 մլն
418,70 մլն
253,80 մլն
264,03 մլն
Total operating expenses
1,36 մլրդ
1,52 մլրդ
1,10 մլրդ
1,23 մլրդ
Operating income
22,48 մլն
-225,20 մլն
-15,46 մլն
-22,45 մլն
Other non operating income
-48,58 մլն
83,13 մլն
-494,88 հզր
-14,66 մլն
EBT including unusual items
2,07 մլն
12,52 մլն
-14,01 մլն
55,01 մլն
EBT excluding unusual items
1,42 մլն
-87,63 մլն
-12,62 մլն
43,62 մլն
Income tax expense
5,30 մլն
15,18 մլն
1,97 մլն
1,66 մլն
Effective tax rate
255,69%
121,26%
-14,09%
3,01%
Other operating expenses
2,71 մլն
24,90 մլն
2,56 մլն
17,29 մլն
Net income
-3,82 մլն
-2,75 մլն
-16,56 մլն
52,60 մլն
Net profit margin
-0,28%
-0,21%
-1,53%
4,34%
Earnings per share
-
-
-
-
Interest and investment income
29,35 մլն
68,16 մլն
4,62 մլն
81,94 մլն
Interest expense
-1,82 մլն
-13,72 մլն
-1,28 մլն
-1,20 մլն
Net interest expenses
27,53 մլն
54,44 մլն
3,34 մլն
80,73 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
92,91 մլն
-156,94 մլն
52,80 մլն
45,08 մլն
Gain or loss from assets sale
286,02 հզր
-846,81 հզր
-
-3,74 մլն
AI content may include mistakes. Learn more
Google Apps